News
Long-term obesity is associated with the expression of biomarkers denoting antagonistic and integrative aging hallmarks in adults aged 28 to 31 years.
BNY Mellon Global Infrastructure Income offers a compelling mix of growth, value, and income, outperforming passive peers.
In this context, two hot-button items are the US push for exports of genetically modified (GM) crops and cow milk to India.
Viridian Therapeutics Inc. (NASDAQ:VRDN) is one of the best low priced pharma stocks to buy now. Earlier on May 20, Viridian ...
Women who developed a cardiovascular disease or type 2 diabetes were at a higher risk of developing breast cancer post ...
SOUTH SAN FRANCISCO, CA, USA I July 14, 2025 I Marea Therapeutics, Inc., a clinical-stage biotechnology company harnessing the latest advances in human ...
Most adults with acromegaly reduced IGF-1 levels and improved acromegaly symptoms with once-monthly subcutaneous octreotide ...
The Palsonify-treated subjects maintained control, with stable growth hormone levels, symptom scores, and pituitary tumour ...
10d
Stocktwits on MSNCrinetics Pharma’s Oral Drug Shows Lasting Relief For Acromegaly Patients In Latest Study; Retail Buzz BuildsRetail chatter around Crinetics Pharmaceuticals picked up late Sunday after the company released long-term data for its oral ...
Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label extensions of PATHFNDR-1 and PATH ...
In patients who transitioned from injected SRLs to once-daily oral PALSONIFY, mean insulin-like growth factor 1 (IGF-1) levels remained stable with IGF-1 (mean ± SE) of 0.93 ± 0.22 at OLE baseline and ...
Data show that PALSONIFY was well tolerated and IGF-1 levels remained stably controlled during long-term open label extensions of PATHFNDR-1 and PATHFNDR-2 studies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results